Blockchain Registration Transaction Record

Stonegate Capital Partners Initiates Coverage on Sirona Biochem Corp, Highlighting GlycoProteMim™ Potential

Stonegate Capital Partners initiates coverage on Sirona Biochem Corp, highlighting the potential of GlycoProteMim™ in the skincare market and the company's target of profitability by 2025.

Stonegate Capital Partners Initiates Coverage on Sirona Biochem Corp, Highlighting GlycoProteMim™ Potential

This news matters as it sheds light on the growth potential of Sirona Biochem Corp and its GlycoProteMim™ product in the skincare industry, ultimately impacting the company's future profitability and market position.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0x9018d56550a39d08039358531c7861f3d3684bf58882c74cd74c70fecbe87f70
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintclubEUAI-3c49ed69e3e12e9a11bc40d6a5f50863